Balaji Amines

Solapur, India Founded: 1988 • Age: 38 yrs Listed
Diversified chemicals including methylamines and pharma excipients are manufactured.

About Balaji Amines

Balaji Amines is a publicly listed company based in Solapur (India) founded in 1988 by Ande Prathap Reddy. Diversified chemicals including methylamines and pharma excipients are manufactured. The company has 21 employees. Its Indian entity Balaji Amines Limited reported revenue of β‚Ή1,454 Cr. Balaji Amines offers products and services including Amines, Derivatives, Speciality Chemicals, and Pharma Excipients. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.

Company details

Balaji Amines was established in 1988 and is headquartered in Solapur, India. Operations focus on the chemical manufacturing sector, where methylamines, ethylamines, derivatives of specialty chemicals, and pharmaceutical excipients are produced. Downstream products are developed for applications in the pharmaceutical and pesticides industries, supporting various industrial needs through diversified chemical outputs.

Recognitions & Rankings of Balaji Amines

India's Most Valuable Companies 2022 edition · Source: Hurun India
Rank#338
Valuation
₹9,801 Cr
2021 #276
  • Headquarters Solapur, India
  • Employees 21
  • Founders Ande Prathap Reddy
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website balajiamines.com
  • Social LinkedIn
  • Legal Name Balaji Amines Limited
Key Metrics
  • Market Cap
    ₹5,758 Cr

    BALAMINES · NSE

  • Share Price
    ₹1,796.70

    +1.10% today

  • Revenue
    ₹1,425 Cr

    FY 2025-26 · +2.0% YoY

  • EBITDA
    ₹265 Cr

    Margin 18.6%

  • Net Profit
    ₹167 Cr

    FY 2025-26 · +6.1% YoY

  • P/E (TTM)
    24.1x

    P/B 2.7x

  • ROE
    8.8%

    ROCE 11.9%

  • Debt / Equity
    0.04

    Interest cover 2.6x

  • Employee Count
    21

Products & Services of Balaji Amines

Balaji Amines offers a comprehensive portfolio of products and services, including Amines, Derivatives, Speciality Chemicals, and Pharma Excipients.

Amines
Chemical Products

Manufacture of methylamines and ethylamines for industrial applications

Derivatives
Specialty Chemicals

Downstream products for pharma and pesticide sectors

Speciality Chemicals
Chemical Products

Custom chemicals meeting user-specific requirements

Pharma Excipients
Healthcare Products

Excipients for pharmaceutical formulations and processes

Board of directors of Balaji Amines Limited (Balaji Amines)

Balaji Amines Limited is the primary company behind Balaji Amines. The boards of the 2 registered companies of Balaji Amines currently have 8 directors; the longest-serving is Pratap Reddy Ande, appointed in 2013. 28 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pratap Reddy Ande
DIN 00003967
Whole-time director01 Apr 201313 yrs 7 moBalaji Amines Limited
Ande Srinivas Reddy
DIN 03169721
Whole-time director30 Sep 201313 yrs 1 moBalaji Amines Limited
Rajeshwar Reddy Nomula
DIN 00003854
Designated Partner26 Sep 20215 yrs 1 moBalaji Speciality Fine Chem Products Llp, Balaji Amines Limited
Ram Reddy Dundurapu
DIN 00003864
Designated Partner26 Sep 20215 yrs 1 moBalaji Speciality Fine Chem Products Llp, Balaji Amines Limited
Suhasini Yatin Shah
DIN 02168705
Director20 May 20233 yrs 5 moBalaji Amines Limited
Uma Rajiv Pradhan
DIN 10096017
Director20 May 20233 yrs 5 moBalaji Amines Limited
Mohan Kumar Ramakrishna
DIN 10168247
Director20 May 20233 yrs 5 moBalaji Amines Limited
Rao Seshagiri Adabala
DIN 09608973
Director20 May 20233 yrs 5 moBalaji Amines Limited

People of Balaji Amines

1 people are tracked at Balaji Amines (1 in leadership); the tracked headcount is 21.

NameRoleGroup
Founder & ChairmanLeadership
Premium access

Complete people profiles for Balaji Amines

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Balaji Amines

Balaji Amines is a publicly listed company on the NSE with ticker symbol BALAMINES in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date05 Apr 2007
  • Listed onNSE: BALAMINES
  • Listed entityBalaji Amines Limited
  • Exchange sectorProcess industries
  • ISININE050E01027
  • Share price₹2,078.60 (-0.26% on the day) · 2026-10-14
  • Market capitalisation₹6,754 Cr
  • Price to earnings33.0
  • EPS (diluted, trailing year)₹63.00
  • Dividend yield0.53%
  • Volume (last session)104,815

Financials of Balaji Amines

Exchange-reported figures of Balaji Amines Limited, the listed company behind Balaji Amines (NSE: BALAMINES).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹1,425 Cr
+2.0% YoY
EBITDA
₹265 Cr
+14.3% YoY
Profit After Tax
₹167 Cr
+6.1% YoY
Net Worth
₹1,976 Cr
+7.1% YoY
Total Assets
₹2,295 Cr
+12.9% YoY
Total Debt
₹133 Cr
+1108.3% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,4251,3971,6422,3552,3231,311936
Revenue growth+2.0%-14.9%-30.3%+1.4%+77.1%+40.2%-
EBITDA265232324609623373181
EBITDA margin+18.6%+16.6%+19.7%+25.9%+26.8%+28.5%+19.3%
Profit before tax232213302567578327131
Net profit167157204324368237105
Net profit margin+11.7%+11.3%+12.5%+13.7%+15.9%+18.1%+11.2%
EPS (β‚Ή)51.6048.6263.22100.47113.7173.5132.34
Balance sheet
Total assets2,2952,0331,9191,7601,4201,058945
Net worth1,9761,8451,7221,5541,250894658
Total debt13311.0319.7057.57101127260
Cash & bank27135434023651.5619.648.81
Net working capital607820857838649372288
Cash flow
Cash from operations184255334354220110144
Cash from investing(344)(139)(274)(210)(147)(61.59)(130)
Cash from financing84.57(48.52)(74.97)(81.23)(56.51)(37.45)(25.67)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue468456395331341358353313
Revenue growth (YoY)+37.3%+27.2%+11.9%+5.9%-1.8%-6.9%--
Other income4.385.527.744.997.059.028.037.86
EBITDA10211694.2556.6759.8154.6959.6745.71
EBITDA margin+21.7%+25.4%+23.9%+17.1%+17.6%+15.3%+16.9%+14.6%
Depreciation15.3213.7813.9514.1714.2813.9712.9011.88
Interest1.341.412.181.510.960.730.860.80
Profit before tax89.3010685.8645.9851.6249.0153.9440.89
Tax21.8328.0921.0915.2314.5312.4913.499.75
Net profit67.4778.1264.7730.7537.0936.5240.4531.14
EPS (β‚Ή)20.7623.1319.999.4910.6711.7312.3610.24
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,2921,2741,3381,7261,9211,228919
Revenue growth+1.4%-4.8%-22.5%-10.1%+56.4%+33.6%-
EBITDA247226247330441327180
EBITDA margin+19.1%+17.8%+18.4%+19.1%+23.0%+26.6%+19.6%
Profit before tax227209232305423310154
Net profit165156171226308231114
Net profit margin+12.8%+12.3%+12.8%+13.1%+16.0%+18.8%+12.4%
EPS (β‚Ή)51.0948.2152.8770.2395.0471.5135.11
Balance sheet
Total assets1,7951,6591,5401,4041,1951,043934
Net worth1,7851,6551,5341,4001,192897668
Total debt0.370.420.000.000.000.00102
Cash & bank27124320616148.1217.667.26
Net working capital667648635623466286225
Cash flow
Cash from operations20022421718717693.92148
Cash from investing(129)(179)(190)(155)(142)(86.55)(130)
Cash from financing(35.74)(37.52)(34.58)(22.17)(20.00)3.02(30.84)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue428423362301309319322299
Revenue growth (YoY)+38.4%+32.4%+12.5%+0.7%-3.4%-4.0%--
Other income6.406.178.405.376.987.275.825.45
Total expenses331319276246259263264248
EBITDA96.9610386.0854.7050.0156.4758.0551.66
EBITDA margin+22.7%+24.5%+23.8%+18.2%+16.2%+17.7%+18.1%+17.3%
Depreciation12.7111.5411.4111.6111.5211.0610.369.85
Interest0.220.271.040.470.430.340.470.41
Profit before tax90.4397.8282.0347.9945.0452.3453.0446.85
Tax21.7125.6720.1715.5813.5912.5413.4311.15

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue468456395331341358353313
Revenue growth (YoY)+37.3%+27.2%+11.9%+5.9%-1.8%-6.9%--
Other income4.385.527.744.997.059.028.037.86
EBITDA10211694.2556.6759.8154.6959.6745.71
EBITDA margin+21.7%+25.4%+23.9%+17.1%+17.6%+15.3%+16.9%+14.6%
Depreciation15.3213.7813.9514.1714.2813.9712.9011.88
Interest1.341.412.181.510.960.730.860.80
Profit before tax89.3010685.8645.9851.6249.0153.9440.89
Tax21.8328.0921.0915.2314.5312.4913.499.75
Net profit67.4778.1264.7730.7537.0936.5240.4531.14
EPS (β‚Ή)20.7623.1319.999.4910.6711.7312.3610.24
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,4251,3971,6422,3552,3231,311936
Revenue growth+2.0%-14.9%-30.3%+1.4%+77.1%+40.2%-
Other income28.8133.2029.6415.2514.726.075.01
Total expenses1,1601,1651,3181,7461,700938755
Employee cost84.1179.8682.2785.2196.6433.5634.07
EBITDA265232324609623373181
EBITDA margin+18.6%+16.6%+19.7%+25.9%+26.8%+28.5%+19.3%
Depreciation56.3848.4445.3745.5742.0034.4131.62
Interest5.373.706.4411.9717.1018.2923.03
Profit before tax232213302567578327131
Tax63.3354.6369.2516116083.1033.63
Net profit167157204324368237105
Net profit margin+11.7%+11.3%+12.5%+13.7%+15.9%+18.1%+11.2%
EPS (β‚Ή)51.6048.6263.22100.47113.7173.5132.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital6.486.486.486.486.486.486.48
Reserves & surplus1,9701,8391,7151,5481,243888652
Shareholders' funds (net worth)1,9761,8451,7221,5541,250894658
Minority interest17517317114465.0115.5310.23
Secured loans13310.6119.7057.57101123256
Unsecured loans0.370.420.000.000.004.004.00
Total debt13311.0319.7057.57101127260
Total liabilities2,2952,0331,9191,7601,4201,058945
Assets
Gross block1,5111,4171,2641,104969790786
Net block1,0431,003896781681543573
Capital work in progress51223820511314117346.27
Investments0.000.000.0072.650.000.0047.50
Inventories247274287303222110109
Sundry debtors346275319378588306207
Cash & bank balances27135434023651.5619.648.81
Loans & advances76.5638.3250.8943.2345.0314288.05
Total current assets941941997960907577413
Total current liabilities334121140122258205125
Net working capital607820857838649372288
Total assets2,2952,0331,9191,7601,4201,058945
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash14981.2096.3633.1317.328.8120.40
Net cash from operating activities184255334354220110144
Net cash from investing activities(344)(139)(274)(210)(147)(61.59)(130)
Net cash from financing activities84.57(48.52)(74.97)(81.23)(56.51)(37.45)(25.67)
Net change in cash(74.97)67.69(15.16)63.2315.8010.83(11.59)
Closing cash27135434023651.5619.648.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.0%-14.9%-30.3%+1.4%+77.1%+40.2%-
EBITDA growth+14.3%-28.3%-46.9%-2.2%+66.8%+106.5%-
PBT growth+9.1%-29.3%-46.8%-2.0%+77.1%+149.1%-20.6%
Net income growth+6.1%-23.0%-36.8%-12.1%+55.1%+126.7%-
Revenue CAGR (3Y)-15.4%-15.6%+7.8%+36.0%+35.1%+15.1%+11.8%
EBITDA CAGR (3Y)-24.2%-28.0%-4.6%+49.9%+47.7%+27.0%+6.6%
Profitability & leverage
Net income margin+11.9%+11.4%+14.2%+17.2%+18.0%+18.6%+10.4%
Return on capital employed+12.0%+12.0%+18.3%+39.0%+49.7%+34.9%+17.6%
Return on net worth+8.9%+8.9%+14.2%+28.9%+39.0%+31.4%+15.8%
Debt / equity0.040.010.020.060.110.250.40
Long-term debt / equity0.020.000.010.030.070.130.16
Interest cover2.572.012.312.122.945.4015.44
Efficiency & per share
Fixed asset turnover0.971.041.392.272.641.661.45
Inventory turnover5.474.985.578.9713.9811.996.88
Debtors turnover4.594.704.714.885.205.115.00
EPS (β‚Ή)51.6048.6263.22100.47113.7173.5132.34
Dividend per share (β‚Ή)11.0011.0011.0010.006.004.003.20
Book value per share (β‚Ή)610.00569.44531.42479.69385.74276.04203.12
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue428423362301309319322299
Revenue growth (YoY)+38.4%+32.4%+12.5%+0.7%-3.4%-4.0%--
Other income6.406.178.405.376.987.275.825.45
Total expenses331319276246259263264248
EBITDA96.9610386.0854.7050.0156.4758.0551.66
EBITDA margin+22.7%+24.5%+23.8%+18.2%+16.2%+17.7%+18.1%+17.3%
Depreciation12.7111.5411.4111.6111.5211.0610.369.85
Interest0.220.271.040.470.430.340.470.41
Profit before tax90.4397.8282.0347.9945.0452.3453.0446.85
Tax21.7125.6720.1715.5813.5912.5413.4311.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,2921,2741,3381,7261,9211,228919
Revenue growth+1.4%-4.8%-22.5%-10.1%+56.4%+33.6%-
Other income28.0222.7820.909.7618.3912.0310.26
Total expenses1,0441,0471,0911,3971,480901739
Employee cost77.1472.9672.3580.2593.4831.4232.71
EBITDA247226247330441327180
EBITDA margin+19.1%+17.8%+18.4%+19.1%+23.0%+26.6%+19.6%
Depreciation45.6038.3733.6531.2629.1723.3424.18
Interest2.281.862.182.737.045.3312.13
Profit before tax227209232305423310154
Tax61.8852.7660.3177.8311578.2639.96
Net profit165156171226308231114
Net profit margin+12.8%+12.3%+12.8%+13.1%+16.0%+18.8%+12.4%
EPS (β‚Ή)51.0948.2152.8770.2395.0471.5135.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital6.486.486.486.486.486.486.48
Reserves & surplus1,7781,6491,5281,3941,186891661
Shareholders' funds (net worth)1,7851,6551,5341,4001,192897668
Secured loans0.000.000.000.000.000.00102
Unsecured loans0.370.420.000.000.000.000.00
Total debt0.370.420.000.000.000.00102
Total liabilities1,7951,6591,5401,4041,1951,043934
Assets
Gross block1,2741,1791,033882752572569
Net block883833724604495344363
Capital work in progress20315414373.7414117346.27
Investments66.0066.0066.0012866.0066.00114
Inventories21625126326720395.9392.18
Sundry debtors296246262260436272191
Cash & bank balances27124320616148.1217.667.26
Loans & advances21.2322.4233.2523.1015.5710055.23
Total current assets804762764711702486346
Total current liabilities13711412888.30237200120
Net working capital667648635623466286225
Total assets1,7951,6591,5401,4041,1951,043934
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash38.4930.9039.2729.7115.377.2620.36
Net cash from operating activities20022421718717693.92148
Net cash from investing activities(129)(179)(190)(155)(142)(86.55)(130)
Net cash from financing activities(35.74)(37.52)(34.58)(22.17)(20.00)3.02(30.84)
Net change in cash35.137.59(8.36)9.5514.3510.39(13.10)
Closing cash27124320616148.1217.667.26
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+1.4%-4.8%-22.5%-10.1%+56.4%+33.6%-
EBITDA growth+9.2%-8.2%-25.2%-25.3%+35.0%+81.7%-
PBT growth+8.8%-9.8%-24.2%-27.8%+36.5%+101.7%-7.4%
Net income growth+5.9%-8.7%-24.3%-26.6%+33.3%+103.2%-
Revenue CAGR (3Y)-9.2%-12.8%+2.9%+23.4%+26.5%+12.6%+11.3%
EBITDA CAGR (3Y)-9.1%-19.9%-9.0%+22.4%+31.6%+21.5%+5.9%
Profitability & leverage
Net income margin+12.8%+12.3%+12.8%+13.2%+16.0%+18.9%+12.4%
Return on capital employed+13.3%+13.2%+15.9%+23.7%+38.4%+31.9%+19.2%
Return on net worth+9.6%+9.8%+11.7%+17.6%+29.5%+29.6%+18.3%
Debt / equity0.000.000.000.000.000.070.16
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover1.130.991.020.921.711.767.80
Efficiency & per share
Fixed asset turnover1.051.151.402.112.902.151.72
Inventory turnover5.544.965.057.3512.8713.057.83
Debtors turnover4.775.025.124.965.425.305.13
EPS (β‚Ή)51.0948.2152.8770.2395.0471.5135.11
Dividend per share (β‚Ή)11.0011.0011.0010.006.004.003.20
Book value per share (β‚Ή)550.90510.86473.56432.19368.01276.97206.06

Web traffic of Balaji Amines

The website of Balaji Amines (balajiamines.com) receives about 3K visits a month.

  • Monthly visits
    3K

    ▼ 38.9% vs previous month

Similar websites

Websites whose visitors overlap most with Balaji Amines. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
qvchemicals.com
100%
View details
indoaminesltd.com
96%
2.4K#7,070,897View details
amines.com
96%
4.1K#4,568,844View details
lookchem.com
96%
222.7K#195,131View details
alkylamines.com
96%
10.6K#2,201,718View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Balaji Amines

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as Balaji Amines (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 515.01 M1,161
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Balaji Amines

Balaji Amines: Aims For Sales Of INR 3,500 Crores To INR 4,000 Crores By FY28-29 With New Products And Full Use Of Expanded Facilities.
Exchange Update β€’ 4 days ago
Balaji Amines: Expects Acetonitrile Production To Hit 1,000 To 1,200 Tons Monthly Starting In December Based On Market Demand.
Exchange Update β€’ 4 days ago
BALAMINES: Q2 REVENUE 4.68B RUPEES VS 3.4B (YOY)
Exchange Update β€’ 7 days ago
BALAMINES: Q2 CONS NET PROFIT 673M RUPEES VS 346M (YOY)
Exchange Update β€’ 7 days ago
BALAMINES: Q2 EBITDA 1.02B RUPEES VS 598M (YOY); Q2 EBITDA MARGIN 21.72% VS 17.56% (YOY)
Exchange Update β€’ 7 days ago
BALAMINES: Rs. 23.36 Crores NSE Block Trade; for ~ 99,455 Shares, at Rs. 2349.30
Exchange Update β€’ 1 month ago
Balaji Amines: Co. Receives Order From Director General Of Foreign Trade Placing It On Denied Entity List
Exchange Update β€’ 1 month ago
Premium access

Complete news archive for Balaji Amines

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balaji Amines

Balaji Amines was founded in 1988.

Balaji Amines is headquartered in Solapur, India. It is registered at Solapur, Maharashtra, India.

Balaji Amines has 21 employees.

The primary company behind Balaji Amines, Balaji Amines Limited, reported revenue of β‚Ή1,454 Cr for FY 2026, up 2% year on year.

Balaji Amines was established in 1988 and is headquartered in Solapur, India. Operations focus on the chemical manufacturing sector, where methylamines, ethylamines, derivatives of specialty chemicals, and pharmaceutical excipients are produced. Downstream products are developed for applications in the pharmaceutical and pesticides industries, supporting various industrial needs through diversified chemical outputs.

Balaji Amines offers Amines, Derivatives, Speciality Chemicals, and Pharma Excipients.

Yes, Balaji Amines is publicly traded on NSE under the ticker symbol BALAMINES.

Balaji Amines is associated with 2 legal entities: Balaji Amines Limited, Balaji Speciality Fine Chem Products Llp.

The legal entities of Balaji Amines currently have 9 directors, including Rajeshwar Reddy Nomula, Ram Reddy Dundurapu, Ande Srinivas Reddy and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available